PhRMA Plan For Rx-Only Medicare Bill Calls For Independence From HCFA
Executive Summary
The White House may be willing to support a Medicare drug benefit that is overseen by an agency other than the Health Care Financing Administration, Pharmaceutical Research & Manufacturers of America President Alan Holmer maintained.
You may also be interested in...
Glaxo SmithKline U.S. Marketing Could Reach 250,000 MDs In One Week
The combined Glaxo SmithKline U.S. sales force would be able to call on 250,000 physicians during the first week of a major product launch, the companies told a Jan. 17 London press briefing on their proposed merger.
Medicare Reform Proposals For Debate In 2000
With Congress returning from recess Jan. 24, approaches to reforming Medicare will grow in importance as an election-year political issue. Announced reform proposals are listed below
PhRMA Moves To Head Off Clinton Assault; Considers Incremental Rx Benefit
The Pharmaceutical Research & Manufacturers of America is attempting to defuse some of the Clinton Administration's rhetoric on drug costs to the elderly ahead of the State of the Union address.